Turner syndrome (TS) and Noonan syndrome (NS) have short stature as a constant feature; however, both conditions can present clinicians with a challenging array of genetic, cardiovascular, developmental, and psychosocial issues. In recent years, important advances have been achieved in each of these areas. This article reviews these two syndromes and provides updates on recent developments in diagnostic evaluation, growth and development, psychological issues, and treatment options for patients with TS and NS.
|Number of pages||22|
|Journal||Endocrinology and Metabolism Clinics of North America|
|State||Published - Dec 2012|
- Estrogen therapy
- Noonan syndrome
- Recombinant human growth hormone
- Turner syndrome